EUTHYROX TABLET 50 mcg

Riik: Singapur

keel: inglise

Allikas: HSA (Health Sciences Authority)

Toimeaine:

LEVOTHYROXINE SODIUM

Saadav alates:

MERCK PTE. LTD.

ATC kood:

H03AA01

Annus:

50 mcg

Ravimvorm:

TABLET

Koostis:

LEVOTHYROXINE SODIUM 50 mcg

Manustamisviis:

ORAL

Retsepti tüüp:

Prescription Only

Valmistatud:

Merck Healthcare KGaA

Volitamisolek:

ACTIVE

Loa andmise kuupäev:

1998-05-06

Infovoldik

EUTHYROX
®

Active ingredient: Levothyroxine sodium 

COMPOSITION 

1 tablet Euthyrox   25 µg contains
  25 microgram levothyroxine sodium. 
1 tablet Euthyrox   50 µg contains
  50 microgram levothyroxine sodium. 
1 tablet Euthyrox   75 µg contains   75 microgram
levothyroxine sodium. 
1 tablet Euthyrox 100 µg contains
100 microgram levothyroxine sodium. 

Other
ingredients: corn starch, croscarmellose sodium, gelatine, lactose
monohydrate, 
magnesium stearate. 

INDICATIONS 



Treatment of benign euthyroid goitre  


Prophylaxis of relapse after surgery for euthyroid goitre 


Substitution therapy in hypothyroidism  


Concomitant therapy during anti-thyroid medicinal
treatment of hyperthyroidism 


Suppression therapy in thyroid cancer  
_ _
_applies only to tablets of 100 microgram: _
• Diagnostic use for thyroid suppression testing.  

DOSAGE AND ADMINISTRATION  
In order to treat each patient according to his/her individual
needs, tablets are available with a 
levothyroxine sodium content ranging from 25 - 200
microgram. Patients therefore usually need 
to take only one tablet per day.  

The dosage recommendations given
are only for guidance. Determination of the individual daily 
dose on the basis of laboratory tests and clinical examinations
is recommended.  

In children with a sound heart
, 
and for neonates where rapid replacement is
important, the entire 
dose may be started. I
n adults, initiation of thyroid hormone therapy at low dose is 
recommended. The dose may be increased gradually every 2 - 4
weeks until the full replacement 
dose is reached. 

In elderly patients, in patients with coronary heart disease, and
in patients with severe or long-
existing hypothyroidism, special caution is required when
initiating therapy with thyroid hormones: 
Treatment is initiated at a low
dose, whi

Toote omadused

EUTHYROX
®
Active ingredient: Levothyroxine sodium
COMPOSITION
1 tablet Euthyrox 25 µg contains 25 microgram levothyroxine sodium.
1 tablet Euthyrox 50 µg contains 50 microgram levothyroxine sodium.
1 tablet Euthyrox 75 µg contains 75 microgram levothyroxine sodium.
1 tablet Euthyrox 100 µg contains 100 microgram levothyroxine sodium.
Other ingredients: corn starch, croscarmellose sodium, gelatine,
magnesium stearate, citric acid,
mannitol.
INDICATIONS
•
Treatment of benign euthyroid goitre
•
Prophylaxis of relapse after surgery for euthyroid goitre
•
Substitution therapy in hypothyroidism
•
Concomitant therapy during anti-thyroid medicinal treatment of
hyperthyroidism
•
Suppression therapy in thyroid cancer
_ _
_applies only to tablets of 100 microgram: _
• Diagnostic use for thyroid suppression testing.
DOSAGE AND ADMINISTRATION
In order to treat each patient according to his/her individual needs,
tablets are available with a
levothyroxine sodium content ranging from 25 - 200 microgram. Patients
therefore usually need
to take only one tablet per day.
The dosage recommendations given are only for guidance. Determination
of the individual daily
dose on the basis of laboratory tests and clinical examinations is
recommended.
In children with a sound heart, and for neonates where rapid
replacement is important, the entire
dose may be started. I
n adults,
initiation of thyroid hormone therapy at low dose is
recommended. The dose may be increased gradually every 2 - 4 weeks
until the full replacement
dose is reached.
In elderly patients, in patients with coronary heart disease, and in
patients with severe or long-
existing hypothyroidism, special caution is required when initiating
therapy with thyroid hormones:
Treatment is initiated at a low dose, which is increased slowly and at
lengthy intervals with
frequent monitoring of thyroid hormones. A maintenance dose lower than
that required for
complete correction of TSH levels may be considered.
Experience has shown that a lower dose is sufficient in lo